What is Iotamotion?
Iotamotion is a specialized medical technology firm dedicated to enhancing surgical outcomes for patients suffering from severe hearing loss. At the core of its value proposition is the iotaSOFT Insertion System, a sophisticated robotic platform designed to facilitate controlled and gentle electrode array insertion. By minimizing trauma to the delicate structures of the cochlea, Iotamotion addresses critical surgical barriers, thereby improving the efficacy and accessibility of cochlear implantation. The company serves a diverse ecosystem of surgeons, hospitals, and patients, positioning itself as a leader in the intersection of robotics and otolaryngology.
How much funding has Iotamotion raised?
Iotamotion has raised a total of $18.4M across 4 funding rounds:
Angel/Seed
$2M
Angel/Seed
$2.5M
Series A
$12M
Debt
$1.9M
Angel/Seed (2017): $2M with participation from Undisclosed
Angel/Seed (2019): $2.5M led by Undisclosed
Series A (2023): $12M supported by Next Level Ventures, ISA Ventures, and Mutual Capital Partners
Debt (2026): $1.9M, investors not publicly disclosed
Key Investors in Iotamotion
Next Level Ventures
Next Level Ventures is a prominent investment firm based in Iowa, managing over $400 million in assets across a diverse portfolio of more than 45 companies. The firm specializes in providing strategic investments ranging from seed funding to growth-stage funding, with typical investments between $0.5 to $5.0 million.
ISA Ventures
ISA Ventures is Iowa's first multi-stage venture capital fund focused on supporting Iowa-based companies through various growth phases, from early-revenue startups to expansion-stage businesses. The fund invests in key industry sectors such as biotechnology, healthcare, education technologies, and agriculture.
Mutual Capital Partners
Mutual Capital Partners is a Cleveland-based venture capital fund that focuses on investing in early-stage software and medical device companies in the Midwest. The firm partners with innovative healthcare startups, providing not just financial support but also guidance and resources to help them succeed.
What's next for Iotamotion?
With this major enterprise-level funding, Iotamotion is poised to scale its operational footprint and deepen its penetration into the global healthcare market. The strategic deployment of this capital will likely focus on expanding clinical adoption of the iotaSOFT system and potentially diversifying its product pipeline to address broader surgical challenges. As the company transitions into a more mature growth phase, the focus will shift toward optimizing supply chain efficiencies and strengthening its competitive moat through continued innovation in robotic-assisted surgical technology. Investors remain optimistic that the firm's unique technological approach will set a new standard for safety and precision in the field of auditory restoration.
See full Iotamotion company page
